us.doctors.discovericl.comFind a Doctor

简体中文 English Safety Information US What Is EVO? EVO Benefits Sharp, Clear Vision Day and Night Tired of Dry Eyes? Harmony w / Natural Eye Procedure Testimonials FAQ Do I Qualify? Back Sharp, Clear Vision Day and Night Tired of Dry Eyes? Harmony w / Natural Eye Do I Qualify? What Is EVO? EVO Benefits Procedure Testimonials FAQ EVO ICL Blog Contact Safety Information International Sites To find your closest EVO ICL doctor, start by searching your location. Enter ZIP Code or City, State 3+ million lenses distributed worldwide Showing 0 Doctors near zip code Sort by : Practice Utilization Distance Enter your zip code or city, state to start viewing results Select Your Region Europe Austria Belgium - Dutch Belgium - French France Germany Italy Netherlands Norway Portugal Slovenia Spain Sweden Switzerland UKIreland North America Canada Canada - French Mexico United States United States - 中文 Latin America English Spanish Portuguese North Africa Arabic French Middle East Middle East عربى Middle East - فارسي Middle East - English Asia Pacific Australia China - 中国 India Japan - 日本 New Zealand S. Korea - 대한민국 South East Asia References 1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438. 2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. 3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53. 4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215. 5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263. 6. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012. 7. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6. 8. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of CataractRefractive Surgery , Volume 26 , Issue 9 , 1326 - 1331. 9. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481. * American Refractive Surgery Council This provider locator tool is being provided by STAAR Surgical® Company (STAAR”) solely to assist users in locating a provider who has experience with the EVO ICL family of lenses, as explained further here. Specifically, the sole criteria for inclusion in the locator is whether a provider is certified by STAAR to implant EVO ICL lenses. Users may search the locator by zip code, state, or current location. Two types of sorting functionality is available within the locator. Users are able to sort the results via distance, or by the frequency with which a healthcare provider has recently used EVO ICL lenses (e.g., within the past 12 months). Irrespective of the sorting method selected, all providers are shown in the results within the queried geographic location. The listed order of providers under any sorting method, including the initial presentation of providers in a geographic location, is based on a variety of factors, including whether the provider maintains consumer-facing information about EVO ICL lenses on its website, the breadth and quality of such information, whether it has demonstrated a commitment to training staff and offering the EVO ICL as a refractive procedure option to qualified patients, and how frequently the provider has performed procedures using the EVO ICL over the past year. Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider. STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool. Important Safety Information The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before. Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if: Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL You are pregnant or nursing You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma) You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor Your vision is not stable as determined by your eye doctor Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com. References Testimonials Safety Information EVO ICL Blog Contact Stay Updated on EVO Visian ICL STAAR Surgical®, as the data controller, would like to contact you periodically to provide information regarding our products, services, events and content that may be of interest to you. By providing your email address, you agree to receive marketing or market research communications from STAAR Surgical® via email. If you wish to stop receiving marketing or market research communications from STAAR Surgical® you can unsubscribe via the link at the bottom of the relevant marketing email at any time. For further information on how we use your personal data please refer to our online a href='https://us.discovericl.com/privacy-policy'Privacy Statement/a. © 2024 STAAR Surgical®. All Rights Reserved. Privacy Policy Terms of use International Sites Cookie Settings Feeling unsure? We get it. Decisions like this take time to consider and research. We can help guide your decision with information that's the most relevant to you. Do you currently wear glasses or contacts? select......